Model the cost-to-value path of your drug asset.
AssetLens estimates development costs, commercial potential, and NPV across go-alone and outlicensing scenarios.
Pricing strategy
Develop your pricing strategy based on real market products and evidence, not assumptions.
Cost assumptions
Based on comparable programs, get projected development costs, timelines, and patient requirements across clinical trial stages.
Deal terms
Understand what deal structures your closest competitors have already signed and get a projection of potential licensing or partnership terms for your asset at different clinical stages.
NPV
Evaluate your projected profit across different licensing strategies and identify which commercialization path creates the strongest asset value.
Real implementations – adapted to each client’s data, infrastructure, and operational needs.
Trusted by Industry Leaders:
Get in touch with us.
We’re here to assist you.
